AVONEX PEN (interferon beta-1a) 30mcg/0.5mL solution for injection by Biogen Idec The Avonex Pen (interferon beta-1a 30mcg/0.5mL solution for injection), the first IM autoinjector for chronic use in ...

Avonex, used to treat certain types of multiple sclerosis, can cause side effects ranging from mild, such as headaches and muscle pain, to serious, including depression and liver damage. Long-term ...

AVONEX PEN (interferon beta-1a) 30mcg/0.5mL solution for injection by Biogen Idec Biogen Idec has received approval from the FDA for Avonex Pen (30mcg/0.5mL solution for injection) for patients ...

Avonex is typically prescribed as a long-term treatment for relapsing forms of multiple sclerosis (MS). The standard dosage is 30 micrograms (mcg) injected into the upper outer thigh muscle once per ...

-- First single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX recommended for approval in the European Union and authorised in Canada -- AVONEX PEN is designed ...

CAMBRIDGE, Mass.-(BUSINESS WIRE) - Data from an observational phase IV study of 499 patients entitled The Swiss MS Skin Project show that multiple sclerosis (MS) patients taking AVONEX (interferon ...

Patients taking the multiple sclerosis (MS) drug Avonex (search) should be watched for possible liver problems, says the drug’s maker. Rare cases of severe liver injury, including cases of liver ...

The late Lawrence Jacobs, MD, a UB professor of neurology, was determined to improve the lives of his patients. His resolve led to groundbreaking research on multiple sclerosis (MS)—most notably the ...

March 17, 2005 — The U.S. Food and Drug Administration (FDA) and Biogen Idec have warned healthcare professionals via letter of rare postmarketing reports of severe hepatic injury in patients ...

Biogen Idec has won European regulatory approval for a new delivery method for its blockbuster multiple sclerosis (MS) drug, Avonex, called the Avonex Pen. This is the first approval for the Avonex ...

Anniversary Celebration Includes NASDAQ Ceremonial Bell Ringing, Educational Events, Commemorative Book and Video Biogen Idec (NASDAQ:BIIB) today marks the 10th anniversary of AVONEX(R) (Interferon ...

Biogen's newly approved, once-monthly MS drug Zinbryta comes with more serious side effects than predecessor Avonex. But the med is safer than a competing treatment ...